News
Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing pressures. Click for my RHHBY update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback